Skip to main content
. 2022 Nov 30;3(1):13–24. doi: 10.1021/jacsau.2c00481

Figure 1.

Figure 1

Structures of nucleoside, cyclic dinucleotide, and oligonucleotide therapeutics. Common chemical modifications used to improve pharmacodynamic and pharmacokinetic properties are highlighted.